Huang, Yixuan
Tang, Yuting
Zhang, Zhanpeng
Shen, Longbin
Guo, Zhenpeng
Chen, Zhuoming
Long, Jinyi
Funding for this research was provided by:
the Shanghai Municipal Health Commission Project (20234Y0140)
the National Key R&D Program of China (2020YFC2005700)
the Key Realm R&D Program of Guangdong Province (2019B030335001)
National Natural Science Foundation of China (No. 62276115)
Outstanding Youth Project of Guangdong Natural Science Foundation of China (No. 2021B1515020076)
Science and Technology Planning Project of Guangdong Province (2023A0505050092)
the Guangzhou Basic and Applied Basic Research Foundation (No. 2024A04J5486)
Article History
Received: 21 April 2025
Accepted: 29 December 2025
First Online: 16 January 2026
Declarations
:
: This randomized controlled trial was approved by the Medical Ethics Committee of the First Affiliated Hospital of Jinan University (Approval No. KY-2020-087). All stroke patients provided written informed consent before participation, and the study protocol adhered to the ethical guidelines of the Declaration of Helsinki. Photographs included in the study were anonymized by obscuring identifiable facial features to ensure participant privacy.
: Not applicable.
: The authors declare no competing interests.